alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 1271.75 How do I screen a donor? ( a ) *All donors.* Except as provided under § 1271.90, if you are the establishment that performs donor screening, you must screen a donor of cells or tissue by reviewing the donor's relevant medical records for: ( 1 ) Risk factors for, and clinical evidence of, relevant communicable disease agents and diseases, including: ( i ) Human immunodeficiency virus;
( ii ) Hepatitis B virus;
( iii ) Hepatitis C virus;
( iv ) Human transmissible spongiform encephalopathy, including Creutzfeldt-Jakob disease;
( v ) *Treponema pallidum* ; and
( 2 ) Communicable disease risks associated with xenotransplantation.
( b ) *Donors of viable, leukocyte-rich cells or tissue.* In addition to the relevant communicable disease agents and diseases for which screening is required under paragraph (a) of this section, and except as provided under § 1271.90, you must screen the donor of viable, leukocyte-rich cells or tissue by reviewing the donor's relevant medical records for risk factors for and clinical evidence of relevant cell-associated communicable disease agents and diseases, including Human T-lymphotropic virus.
( c ) *Donors of reproductive cells or tissue.* In addition to the relevant communicable disease agents and diseases for which screening is required under paragraphs (a) and (b) of this section, as applicable, and except as provided under § 1271.90, you must screen the donor of reproductive cells or tissue by reviewing the donor's relevant medical records for risk factors for and clinical evidence of infection due to relevant communicable diseases of the genitourinary tract. Such screening must include screening for the communicable disease agents listed in paragraphs (c)(1) and (c)(2) of this section. However, if the reproductive cells or tissues are recovered by a method that ensures freedom from contamination of the cells or tissue by infectious disease organisms that may be present in the genitourinary tract, then screening for the communicable disease agents listed in paragraphs (c)(1) and (c)(2) of this section is not required. Communicable disease agents of the genitourinary tract for which you must screen include: ( 1 ) *Chlamydia trachomatis* ; and
( 2 ) *Neisseria gonorrhea.*
( d ) *Ineligible donors.* You must determine ineligible a donor who is identified as having either of the following: ( 1 ) A risk factor for or clinical evidence of any of the relevant communicable disease agents or diseases for which screening is required under paragraphs (a)(1), (b), or (c) of this section; or
( 2 ) Any communicable disease risk associated with xenotransplantation.
( e ) *Abbreviated procedure for repeat donors.* If you have performed a complete donor screening procedure on a living donor within the previous 6 months, you may use an abbreviated donor screening procedure on repeat donations. The abbreviated procedure must determine and document any changes in the donor's medical history since the previous donation that would make the donor ineligible, including relevant social behavior.
[66 FR 5466, Jan. 19, 2001, as amended at 71 FR 14798, Mar. 24, 2006]
EXHIBIT 32.1
                                                                    ------------

                                  CERTIFICATION
                  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
          ACT OF 2002 (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER
                       63 OF TITLE 18, UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of National Datacomputer, Inc., a Delaware corporation (the
"Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-QSB for the period ended March 31, 2006 (the
"Form 10-QSB") of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, and the information
contained in the Form 10-QSB fairly presents, in all material respects, the
financial condition and results of operations of the Company.


Dated: May 16, 2006                     /s/ William B. Berens
                                        ------------------------
                                        William B. Berens
                                        President and Chief Executive Officer

Dated: May 16, 2006                     /s/ Bruna Bucacci
                                        ------------------------
                                        Bruna Bucacci
                                        Chief Accounting Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 959 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
H. RES. 959

   To express support for recognition of June 2018 as National Orca 
                           Protection Month.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 22, 2018

     Mr. Heck (for himself, Mr. Kilmer, Ms. DelBene, Mr. Smith of 
Washington, Mr. Larsen of Washington, Ms. Jayapal, Mr. Blumenauer, and 
Ms. Lee) submitted the following resolution; which was referred to the 
              Committee on Oversight and Government Reform

_______________________________________________________________________

                               RESOLUTION

 
   To express support for recognition of June 2018 as National Orca 
                           Protection Month.

Whereas orcas are an icon of the Pacific Northwest;
Whereas orcas are culturally and spiritually important to Indian tribes in the 
        Pacific Northwest;
Whereas the Puget Sound is home to three pods of Southern Resident orcas;
Whereas the Southern Resident orca population has declined dramatically over the 
        past 50 years;
Whereas the Southern Resident orcas are among the most contaminated marine 
        mammals in the world;
Whereas the Southern Resident orcas are threatened by declining chinook salmon 
        populations;
Whereas the Southern Resident orcas have been protected under the Endangered 
        Species Act of 1973 (16 U.S.C. 1531 et seq.) since 2005 and are one of 
        the most endangered marine mammal populations in the world;
Whereas the Southern Resident orca population reached its lowest level in 34 
        years in 2018, with 13 fewer whales than when the population was listed 
        under the Endangered Species Act of 1973;
Whereas June 2018 has been recognized by the States of Washington and Oregon as 
        Orca Awareness Month; and
Whereas the Federal Government has an obligation to protect and restore the 
        Southern Resident orca population: Now, therefore, be it
    Resolved, That the House of Representatives supports recognition of 
National Orca Protection Month.
                                 <all>
```
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT


TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Form 10-Q of DOR BioPharma, Inc. (the “Company”) for the
fiscal quarter ended March 31, 2009, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), the undersigned hereby certifies,
pursuant to 18 U.S.C. Section 1350, that:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.











May
      14, 2009
            
            /s/ Christopher J.
  SchaberChristopher
      J. Schaber, Ph.D.President
      and Chief Executive Officer(Principal
      Executive Officer)
38333.

#### ALEXANDER, by Next Friend v. EMPLOYERS MUTUAL LIABILITY INSURANCE COMPANY *et al.*

Decided November 30, 1960.

*Greene, Neely, Buckley ,& DeRieux, Grace W. Thomas, Burt DeRieux,*for plaintiff in error.

*Smith, Swift, Currie, McGhee & Hancock, E. B. Shaw,*contra.

Carlisle, Judge.

Where the facts adduced upon the hearing before the single director of the State Board of Workmen’s Compensation show that the claimant was a minor natural child of the deceased employee who was killed as the result of an injury arising out of and in the course of his employment; that the claimant’s mother and father had been divorced and the mother remarried; and, that the claimant had been legally adopted by his mother’s second husband and wholly supported by him, under the ruling in *New Amsterdam Casualty Co. v. Freeland,*216 Ga. 492, such claimant was not entitled to recover compensation as a dependent of the deceased employee, and the judge of the superior court did not err in reversing the award of the single director granting-compensation.

*Judgment affirmed.*

*Townsend, P. J., Frankum kind Jordan, JJ., concur.*
<TABLE> <S> <C>

<ARTICLE> BD
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-28-1997
<CASH>                                          44,404
<RECEIVABLES>                                1,132,610
<SECURITIES-RESALE>                            117,674
<SECURITIES-BORROWED>                           15,059
<INSTRUMENTS-OWNED>                             43,915
<PP&E>                                          54,054
<TOTAL-ASSETS>                               1,502,043
<SHORT-TERM>                                         0
<PAYABLES>                                   1,017,703
<REPOS-SOLD>                                         0
<SECURITIES-LOANED>                            181,475
<INSTRUMENTS-SOLD>                              10,162
<LONG-TERM>                                     26,972
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,100
<OTHER-SE>                                     262,631
<TOTAL-LIABILITY-AND-EQUITY>                 1,502,043
<TRADING-REVENUE>                               21,056
<INTEREST-DIVIDENDS>                            24,985
<COMMISSIONS>                                   38,859
<INVESTMENT-BANKING-REVENUES>                      791
<FEE-REVENUE>                                        0
<INTEREST-EXPENSE>                              10,881
<COMPENSATION>                                  31,278
<INCOME-PRETAX>                                 22,516
<INCOME-PRE-EXTRAORDINARY>                      22,516
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    14,241
<EPS-PRIMARY>                                     0.42
<EPS-DILUTED>                                     0.42
        

</TABLE>
§ 146.135 Orange juice. ( a ) Orange juice is the unfermented juice obtained from mature oranges of the species *Citrus sinensis* or of the citrus hybrid commonly called “Ambersweet” (1 ⁄ 2 *Citrus sinensis* X 3 ⁄ 8 *Citrus reticulata* X 1 ⁄ 8 *Citrus paradisi* (USDA Selection:1-100-29: 1972 Whitmore Foundation Farm)). Seeds (except embryonic seeds and small fragments of seeds that cannot be separated by current good manufacturing practice) and excess pulp are removed. The juice may be chilled, but it is not frozen.
( b ) The name of the food is “orange juice”. The name “orange juice” may be preceded on the label by the varietal name of the oranges used, and if the oranges grew in a single State, the name of such State may be included in the name, as for example, “California Valencia orange juice”.
[42 FR 14433, Mar. 15, 1977, as amended at 57 FR 57667, Dec. 7, 1992]
# m8806.docx

EUROPEAN COMMISSION Brussels, 19.3.2018 C(2018) 1758 final To t he notifying part y Subject : Case M. 8806 - RICHEMONT / YOOX NET-A-PORTER GROUP Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 23 February 2018 , the European Commission received notification of a proposed conc entration pursuant to Article 4 of the Merger Regulation by which the undertaking C ompagnie Financière Richemont S . A . ( ‘ Richemont ’, Switzerland ) , through its wholly ‐ owned subsidiary RLG Italia Holding S . p . A . (' Bidco ', Italy), acquire s within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the undertaking Yoox Net ‐a ‐ Porter Group S . p . A . (‘YNAP’, Italy ) by way of a public bid . 3 2. The business activities of the undertakings concerned are: - Richemont is a Swiss-based holding company for a range of luxury consumer goods and businesses. Through its various Maisons , Richemont is active in the design, production and distribution of luxury goods, - YNAP is an Italian-based online retailer of luxury consumer goods, listed on the Mercato Telematico Azionario managed by Borsa Italiana SpA , the Milan stock exchange. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(c ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission
(S igned)
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 077 , 01 . 03 . 2018 , p. 6 .
(4)
OJ C 366, 14.12.2013, p. 5 .
IV 

115TH CONGRESS 

1ST SESSION H. RES. 263 

Expressing support for the designation of May 4, 2017, as a ‘‘National 

Day of Reason’’ and recognizing the importance of reason in the betterment of humanity. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 6, 2017 

Mr. TED LIEU of California (for himself, Ms. NORTON, Mr. RASKIN, and Ms. 

LOFGREN) submitted the following resolution; which was referred to the 

Committee on Oversight and Government Reform 

RESOLUTION 

Expressing support for the designation of May 4, 2017, 

as a ‘‘National Day of Reason’’ and recognizing the 

importance of reason in the betterment of humanity. 

Whereas the application of reason has proven to offer hope 

for human survival upon Earth, improving conditions 

within the universe, and cultivating intelligent, moral, 

and ethical interactions among people and their environments; 

Whereas those who wrote the Constitution of the United 

States, the basic document for governing the affairs of 

humankind within the United States, based it upon principles delineated within the philosophies distinguishing 

the historical Age of Reason; 


sradovich on DSK3GMQ082PROD with BILLS
2 

•HRES 263 IH 

Whereas most citizens of the United States purport to value 

reason and its application; 

Whereas it is the duty and responsibility of every citizen to 

promote the development and application of reason; and 

Whereas May 4, 2017, would be an appropriate date to designate as a ‘‘National Day of Reason’’: Now, therefore, 

be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of ‘‘National Day 

3 of Reason’’; and 

4 (2) encourages all citizens, residents, and visi5 tors to join in observing this day and focusing upon 

6 the employment of reason, critical thought, the sci7 entific method, and free inquiry to the resolution of 

8 human problems and for the welfare of humankind. 

Æ 


sradovich on DSK3GMQ082PROD with BILLS
Exhibit 31.2
 
 Control Certification:
 
 
 I, Richard K Brock, certify that:
 
 1.  I have reviewed this annual report on Form 10-KSB of Semele Group Inc;
 
 2.  Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
 3.  Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
 
 4.  The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
 
 a)  designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
 
 b)  evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the Evaluation Date); and
 
 c)  presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
 
 5.  The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
 
 d)  all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and
 
 e)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
 
 6.  The registrants other certifying officer and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
 
 /s/ Richard K Brock
 Richard K Brock
 Vice President and Chief Financial Officer
 August 23, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### National Oceanic and Atmospheric Administration

          - 15 CFR Part 902
          - 50 CFR Part 300
          - [Docket No. 070717350-9936-02]
          - RIN 0648-AV63

# AGENCY:

National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

# ACTION:

Final rule; correction.

# SUMMARY:

This action corrects the effective date of final regulations published in the Federal Register on January 21, 2010, from February 22, 2010, to April 21, 2010. The rule establishes regulations needed to carry out the obligations of the United States under the Convention on the Conservation and Management of Highly Migratory Fish Stocks in the Western and Central Pacific Ocean (Convention). The regulations include requirements related to permitting, vessel monitoring systems, vessel observers, vessel markings, reporting and recordkeeping, at-sea transshipment, and boarding and inspection on the high seas, among others. The rule will have the effect of requiring that all relevant U.S. fishing vessels are operated in conformance with the provisions of the Convention.

# DATES:

The effective date of the final regulations published in the Federal Register on January 21, 2010, at 75 FR 3335, is April 21, 2010.

# FOR FURTHER INFORMATION CONTACT:

Tom Graham, NMFS Pacific Islands Region, 808-944-2219.

# SUPPLEMENTARY INFORMATION:

## Need for Correction

                    In the document published January 21, 2010 (75 FR 3335), under the                     **DATES**                     section, the effective date of the final rule was erroneously stated as being February 22, 2010. This document corrects the effective date to read as follows:                

**DATES:**                     This final rule is effective April 21, 2010.                

Authority:16 U.S.C. 5501 et seq; 16 U.S.C. 6901 et seq. 

Dated: February 12, 2010.

Samuel D. Rauch III,

Deputy Assistant Administrator for Regulatory Programs, National Marine Fisheries Service.

[FR Doc. 2010-3277 Filed 2-18-10; 8:45 am]

BILLING CODE 3510-22-S
#### UNITED STATES of America, Plaintiff—Appellee, v. Troy V. CLEVELAND, Defendant-Appellant.

No. 05-6662.

United States Court of Appeals, Fourth Circuit.

Submitted Sept. 30, 2005.

Decided Oct. 18, 2005.

Troy V. Cleveland, Appellant Pro Se. James L. Trump, Office of the United States Attorney, Alexandria, Virginia, for Appellee.

Before WILKINSON, TRAXLER, and KING, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM:

Troy V. Cleveland appeals the district court’s order denying relief on his motion construed as a request for reconsideration pursuant to Fed.R.Civ.P. 60(b).* We have reviewed the record and find no reversible error. Accordingly, we affirm on the reasoning of the district court. *See United States v. Cleveland,*Nos. CR-93-402; CA-99-1030 (E.D.Va. Apr. 7, 2005). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED*

*

 The motion was styled " 'Ends of Justice’ Motion Pursuant to the All Writs Act Under 28 U.S.C. § 1651(a)” and "request[ed] reconsideration” of the denial of a 28 U.S.C. § 2255 (2000) motion.